Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
4.310
-0.090 (-2.05%)
At close: Feb 21, 2025, 4:00 PM
4.029
-0.281 (-6.51%)
After-hours: Feb 21, 2025, 7:42 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $1.74 million as of February 21, 2025. Its market cap has increased by 219.06% in one year.
Market Cap
1.74M
Enterprise Value
-4.80M
1-Year Change
219.06%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $1.74M, a decrease of -98.08%. That is a compound annual growth rate of -60.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.74M | -41.57% |
| Dec 31, 2024 | 2.98M | -5.49% |
| Dec 29, 2023 | 3.15M | -29.48% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.83M | -28.42% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.05B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |